RBC Capital Downgrades AVEO Pharmaceuticals (AVEO) to Underperform

December 16, 2013 7:45 AM EST Send to a Friend
Get Alerts AVEO Hot Sheet
Price: $1.27 +6.72%

Rating Summary:
    1 Buy, 7 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 24 | New: 21
Trade AVEO Now!
Join SI Premium – FREE
RBC Capital downgraded AVEO Pharmaceuticals (NASDAQ: AVEO) from Sector Perform to Underperform with a price target of $2.00 (from $5.00).

For an analyst ratings summary and ratings history on AVEO Pharmaceuticals click here. For more ratings news on AVEO Pharmaceuticals click here.

Shares of AVEO Pharmaceuticals closed at $1.71 yesterday.

You May Also Be Interested In

Related Categories

Analyst PT Change, Downgrades

Related Entities

RBC Capital

Add Your Comment